ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Baltimore Names President, Caltech; Watson, Weinberg, Win National Medals of Science

May 16, 1997

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials.

May 11, 2001

DCE Board Approve Concepts For Contract Recompetitions

November 23, 1984

Also in this 8-page issue: Bush nominates McClellan to head CMS.

February 27, 2004

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001